Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
11.11
+0.44 (4.12%)
At close: Mar 9, 2026, 4:00 PM EDT
11.10
-0.01 (-0.09%)
After-hours: Mar 9, 2026, 6:05 PM EDT

Phathom Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Market Capitalization
8751,180555523462596
Upgrade
Market Cap Growth
131.11%112.56%6.22%13.23%-22.48%-36.35%
Upgrade
Enterprise Value
1,3351,628740535464461
Upgrade
Last Close Price
11.1116.598.129.1311.2219.67
Upgrade
PS Ratio
5.006.7410.05766.45--
Upgrade
PB Ratio
--2.69-2.19-7.18-6.178.25
Upgrade
P/TBV Ratio
-----8.25
Upgrade
EV/Sales Ratio
7.629.3013.39785.10--
Upgrade
Debt / Equity Ratio
-1.34-1.34-2.19-6.13-2.761.27
Upgrade
Net Debt / Equity Ratio
-1.05-1.05-1.02-0.89-0.68-1.27
Upgrade
Net Debt / EBITDA Ratio
-2.88-2.88-0.93-0.39-0.300.68
Upgrade
Net Debt / FCF Ratio
-2.75-2.75-0.96-0.46-0.350.62
Upgrade
Asset Turnover
0.550.550.140.00--
Upgrade
Inventory Turnover
5.185.183.61---
Upgrade
Quick Ratio
1.581.583.929.885.929.69
Upgrade
Current Ratio
1.731.734.2010.256.129.86
Upgrade
Return on Equity (ROE)
------108.01%
Upgrade
Return on Assets (ROA)
-31.37%-31.37%-43.78%-36.14%-60.85%-34.85%
Upgrade
Return on Capital Employed (ROCE)
-125.90%-125.90%-94.80%-44.60%-124.40%-79.20%
Upgrade
Earnings Yield
-25.27%-18.75%-60.21%-38.57%-42.83%-24.16%
Upgrade
FCF Yield
-19.08%-14.15%-48.07%-26.63%-31.97%-24.98%
Upgrade
Buyback Yield / Dilution
-15.42%-15.42%-23.18%-31.11%-5.72%-11.36%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.